Skip to content

Clinical trials

Invasive Fungal Infections trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Invasive Fungal Infections Country / region: South Korea Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20092
20103
20171
20182
20201
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated2
Recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center3
Astellas Pharma Inc2
Astellas Pharma Singapore Pte. Ltd.1
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Dongkook Pharmaceutical Co., Ltd.1
F2G Biotech GmbH1
F2G Ltd1
Merck Sharp & Dohme LLC1
Samsung Medical Center1
Seoul National University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Invasive Fungal Infections13
Aspergillosis3
Candidemia2
Candidiasis, Invasive2
Candidiasis1
Coccidioidomycosis1
Febrile Neutropenia1
Fungemia1
Graft vs Host Disease1
Hematologic Neoplasms1

Trials

Showing 26 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.